Breast Cancer
From the Journals
Novel fluorescence guidance improves lumpectomy outcomes
Pegulicianine (Lumisight), an investigational and activatable fluorescent imaging agent used with a novel direct visualization system, helped...
From the Journals
Study shows higher obesity-related cancer mortality in areas with more fast food
An ecologic study showed a dose-response relationship among measures of food swamp and food desert scores and obesity-related cancer mortality.
Conference Coverage
Expert discusses which diets are best, based on the evidence
The Mediterranean diet is not only helpful for losing weight but also can reduce the risk of various chronic diseases.
From the Journals
Adherence to cancer prevention guidance linked with reduced breast cancer recurrence, death risk
The study population included patients diagnosed with triple-negative breast cancer and HER2-positive breast cancer.
From the Journals
Cancer pain declines with cannabis use
Lower use of other meds was also seen in patients who used cannabis.
From the Journals
The next big thing in cancer research
Despite significant progress, there is still a lot of work to do.
Conference Coverage
Guidelines for assessing cancer risk may need updating
Whole-exome sequencing reveals cancer risk mutations in patients that would not have qualified for testing based on current guidelines.
From the Journals
Breast cancer screening advice ‘dangerous’ for black women
The current “one-size-fits-all” policy to screen the entire female population from a certain age may be “neither fair and equitable nor optimal...
Conference Coverage
Circulating DNA has promise for cancer detection, but faces challenges
Unnecessary procedures and health care challenges could leave Whites as the primary beneficiaries.
Latest News
Insurers refusing MRI for women at high risk for breast cancer
Compared with 2020, there were significantly more denials, and denials on appeal, in 2021. The addition of MRI to mammography is a standard...
From the Journals
AFib risk with cancer drugs underestimated
Many cancer therapies increase the risk of atrial fibrillation, but this is underreported in clinical trials.